Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
314 results
D3.18 - Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population
D3.19 - Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years
D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media
D3.203 - Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts
D3.205 - Online Education Increases Clinician Knowledge and Confidence in Utilizing Allergen Immunotherapy for Respiratory Allergic Disease
D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool
D3.23 - Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre
D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis
D3.28 - Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
D3.29 - Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients
D3.30 - Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study
D3.31 - Successful Management of Primary Cold Urticaria in Medical Practitioners: A Small Case Series
D3.33 - Severe Eosinophilic Esophagitis: the Key Role of Biologics in Disease Management
D3.47 - Implementing Penicillin Delabelling in an Inpatient setting
D3.49 - Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study
D3.50 - Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists
D3.51 - Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists
D3.54 - Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?
D3.56 - Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics
D3.57 - Isoniazid-Induced Lupus in a Filipino Female: A Case Report
Pagination
First page
First
Previous page
Previous
…
Page
5
Page
6
Page
7
Page
8
Current page
9
Page
10
Page
11
Page
12
Page
13
…
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download